Bonuccelli U - Search Results

1

Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's disease.

Napolitano A, Del Dotto P, Petrozzi L, Dell'Agnello G, Bellini G, Gambaccini G, Bonuccelli U. Napolitano A, et al. Among authors: bonuccelli u. Clin Neuropharmacol. 1999 Jan-Feb;22(1):24-9. doi: 10.1097/00002826-199901000-00005. Clin Neuropharmacol. 1999. PMID: 10047930

2

Clinical and pharmacokinetic evaluation of L-dopa and cabergoline cotreatment in Parkinson's disease.

Del Dotto P, Colzi A, Musatti E, Strolin Benedetti M, Persiani S, Fariello R, Bonuccelli U. Del Dotto P, et al. Among authors: bonuccelli u. Clin Neuropharmacol. 1997 Oct;20(5):455-65. doi: 10.1097/00002826-199710000-00011. Clin Neuropharmacol. 1997. PMID: 9331523 Clinical Trial.

3

Diurnal motor variations to repeated doses of levodopa in Parkinson's disease.

Bonuccelli U, Del Dotto P, Lucetti C, Petrozzi L, Bernardini S, Gambaccini G, Rossi G, Piccini P. Bonuccelli U, et al. Clin Neuropharmacol. 2000 Jan-Feb;23(1):28-33. doi: 10.1097/00002826-200001000-00006. Clin Neuropharmacol. 2000. PMID: 10682228 Clinical Trial.

4

SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

Dell'Agnello G, Ceravolo R, Nuti A, Bellini G, Piccinni A, D'Avino C, Dell'Osso L, Bonuccelli U. Dell'Agnello G, et al. Among authors: bonuccelli u. Clin Neuropharmacol. 2001 Jul-Aug;24(4):221-7. doi: 10.1097/00002826-200107000-00005. Clin Neuropharmacol. 2001. PMID: 11479393

5

Naloxone partly counteracts apomorphine side effects.

Bonuccelli U, Piccini P, Del Dotto P, Rossi G, Corsini GU, Muratorio A. Bonuccelli U, et al. Clin Neuropharmacol. 1991 Oct;14(5):442-9. doi: 10.1097/00002826-199110000-00009. Clin Neuropharmacol. 1991. PMID: 1742754 Clinical Trial.

6

[Diurnal worsening in Parkinson patients treated with levodopa].

Piccini P, Del Dotto P, Pardini C, D'Antonio P, Rossi G, Bonuccelli U. Piccini P, et al. Among authors: bonuccelli u. Riv Neurol. 1991 Nov-Dec;61(6):219-24. Riv Neurol. 1991. PMID: 1813974 Clinical Trial. Italian.

7

[The apomorphine test for diagnosis of parkinsonian syndrome].

Piccini P, Del Dotto P, Napolitano A, Pardini C, Bonuccelli U. Piccini P, et al. Among authors: bonuccelli u. Riv Neurol. 1990 Nov-Dec;60(6):221-3. Riv Neurol. 1990. PMID: 2100046 Clinical Trial. Italian.

8

Cabergoline improves motor disability without modifying L-dopa plasma levels in fluctuating Parkinson's disease patients.

Del Dotto P, Colzi A, Pardini C, Lucetti C, Dubini A, Grimaldi R, Bonuccelli U. Del Dotto P, et al. Among authors: bonuccelli u. J Neural Transm Suppl. 1995;45:259-65. J Neural Transm Suppl. 1995. PMID: 8748633

9

Clozapine in Parkinson's disease tremor. Effects of acute and chronic administration.

Bonuccelli U, Ceravolo R, Salvetti S, D'Avino C, Del Dotto P, Rossi G, Murri L. Bonuccelli U, et al. Neurology. 1997 Dec;49(6):1587-90. doi: 10.1212/wnl.49.6.1587. Neurology. 1997. PMID: 9409351 Clinical Trial.

10

Mexiletine in the treatment of torticollis and generalized dystonia.

Lucetti C, Nuti A, Gambaccini G, Bernardini S, Brotini S, Manca ML, Bonuccelli U. Lucetti C, et al. Among authors: bonuccelli u. Clin Neuropharmacol. 2000 Jul-Aug;23(4):186-9. doi: 10.1097/00002826-200007000-00003. Clin Neuropharmacol. 2000. PMID: 11020121 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

447 results

Search Page

Filters